KER Stock Analysis: Kering | PA
Luxury Goods | PA, France | Market Cap: 33.475m EUR | 12M Return: 24.2% | FR0000121485 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 80.7M
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Kering SA is a Paris-based luxury conglomerate that operates and develops a portfolio of premium fashion, leather goods, and jewelry houses across global markets including Asia Pacific, Western Europe, North America, and Japan. The company offers ready-to-wear, accessories, leather goods, shoes, watches, jewelry, eyewear, fragrances, and cosmetics for men and women under brands such as Gucci, Saint Laurent, Bottega Veneta, Balenciaga, Alexander McQueen, Boucheron, Pomellato, Qeelin, and Ginori 1735, alongside its in-house Kering Eyewear and Kering Beauté divisions.
The group follows a multi-brand holding structure common in the Apparel, Accessories & Luxury Goods sub-industry, retaining direct ownership of its maisons rather than relying primarily on licensing arrangements, and operating dedicated verticals for eyewear and beauty. Founded in 1963 and formerly known as PPR SA, the company adopted its current name in May 2013.
- Gucci revenue decline deepens amid brand repositioning costs
- China luxury demand weakness pressures Asia sales
- Kering Eyewear margin expansion offsets core brand drag
| Net Income: -213.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 3.86 > 1.0 |
| NWC/Revenue: 51.53% < 20% (prev 17.56%; Δ 33.97% < -1%) |
| CFO/TA 0.09 > 3% & CFO 3.40b > Net Income -213.0m |
| Net Debt (15.5b) to EBITDA (3.53b): 4.40 < 3 |
| Current Ratio: 2.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (122.8m) vs 12m ago 0.13% < -2% |
| Gross Margin: 71.92% > 18% (prev 73.03%; Δ -1.11% > 0.5%) |
| Asset Turnover: 34.79% > 50% (prev 37.15%; Δ -2.36% > 0%) |
| Interest Coverage Ratio: 2.43 > 6 (EBIT TTM 1.51b / Interest Expense TTM 622.0m) |
| DSRI: 0.88 (Receivables 1.26b/1.59b, Revenue 14.3b/15.8b) |
| GMI: 1.02 (GM 73.03% / 71.92%) |
| AQI: 0.90 (AQ_t 0.41 / AQ_t-1 0.46) |
| SGI: 0.91 (Revenue 14.3b / 15.8b) |
| TATA: -0.09 (NI -213.0m - CFO 3.40b) / TA 39.8b) |
| Beneish M = -3.25 (Cap -4..+1) = AA |
As of August 18, 2026, the stock is trading at EUR 257.10 with a total of 362,323 shares traded. Over the past week, the price has changed by -9.28%, over one month by +1.90%, over three months by +8.55% and over the past year by +24.15%.
Current recommended Stop Loss: 234.80 (which is 8.7% or 2.3 ATR below the current price).
Kering has no consensus analysts rating.
P/E Forward = 42.5532
P/S = 2.3156
P/B = 2.3995
P/EG = 1.2852
Revenue TTM = 14.3b EUR
EBIT TTM = 1.51b EUR
EBITDA TTM = 3.53b EUR
Long Term Debt = 9.78b EUR (from longTermDebt, last quarter)
Short Term Debt = 2.97b EUR (from shortTermDebt, last quarter)
Debt = 24.0b EUR (from shortLongTermDebtTotal, last quarter) + Leases 6.10b
Net Debt = 15.5b EUR (calculated: Debt 24.0b - CCE 8.48b)
Enterprise Value = 49.0b EUR (33.5b + Debt 24.0b - CCE 8.48b)
Interest Coverage Ratio = 2.43 (Ebit TTM 1.51b / Interest Expense TTM 622.0m)
EV/FCF = 19.00x (Enterprise Value 49.0b / FCF TTM 2.58b)
FCF Yield = 5.26% (FCF TTM 2.58b / Enterprise Value 49.0b)
FCF Margin = 18.02% (FCF TTM 2.58b / Revenue TTM 14.3b)
Net Margin = -1.49% (Net Income TTM -213.0m / Revenue TTM 14.3b)
Gross Margin = 71.92% ((Revenue TTM 14.3b - Cost of Revenue TTM 4.02b) / Revenue TTM)
Gross Margin QoQ = 71.61% (prev 72.25%)
Tobins Q-Ratio = 1.23 (Enterprise Value 49.0b / Total Assets 39.8b)
Interest Expense / Debt = 2.59% (Interest Expense 622.0m / Debt 24.0b)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = 1.13b (EBIT 1.51b * (1 - 25.00%))
Current Ratio = 2.05 (Total Current Assets 14.4b / Total Current Liabilities 7.04b)
Debt / Equity = 1.66 (Debt 24.0b / totalStockholderEquity, last quarter 14.5b)
Debt / EBITDA = 4.40 (Net Debt 15.5b / EBITDA 3.53b)
Debt / FCF = 6.02 (Net Debt 15.5b / FCF TTM 2.58b)
Total Stockholder Equity = 14.7b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.52% (Net Income -213.0m / Total Assets 39.8b)
RoE = -1.45% (Net Income TTM -213.0m / Total Stockholder Equity 14.7b)
RoCE = 6.17% (EBIT 1.51b / Capital Employed (Equity 14.7b + L.T.Debt 9.78b))
RoIC = 3.24% (NOPAT 1.13b / Invested Capital 35.0b)
WACC = 5.12% (E(33.5b)/V(57.5b) * Re(7.40%) + D(24.0b)/V(57.5b) * Rd(2.59%) * (1-Tc(0.25)))
Discount Rate = 7.40% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -57.24 | Cagr: -0.58%
[DCF] Terminal Value 77.97% ; FCFF base≈1.99b ; Y1≈2.28b ; Y5≈3.36b
[DCF] Fair Price = 285.6 (EV 50.5b - Net Debt 15.5b = Equity 35.0b / Shares 122.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -82.32 | EPS CAGR: -62.94% | SUE: N/A | # QB: 0
Revenue Correlation: -99.25 | Revenue CAGR: -12.51% | SUE: N/A | # QB: 0
EPS current Quarter (2026-03-31): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS next Quarter (2026-06-30): EPS=0.00 | Chg30d=N/A | Revisions=N/A | Analysts=0
EPS current Year (2026-12-31): EPS=6.44 | Chg30d=-0.74% | Revisions=-47% | GrowthEPS=+48.7% | GrowthRev=+0.7%
EPS next Year (2027-12-31): EPS=9.97 | Chg30d=+1.95% | Revisions=-28% | GrowthEPS=+54.9% | GrowthRev=+6.2%
[Analyst] Revisions Ratio: -41% (up=8, down=21)